BioGaia GASTRUS 30 chewable tablets

BioGaia GASTRUS 30 chewable tablets

Sale Price:$41.00 Original Price:$44.10

BioGaia GASTRUS

Lactobacillus reuteri DSM 17938 & ATCC PTA 6475 Probiotic

BioGaia Gastrus is a food probiotic supplement containing the patented human origin lactic acid bacterium Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri).

Because both Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 6475 strains in Gastrus naturally colonize humans they have a strong adaptation to persist and interact with humans. BioGaia Gastrus has been tested in clinical trials and proven effective and safe. There are over 200 studies involving more than 19,000 people studying the effects of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475 strains

Quantity:
sale
Add To Cart

What is Limosilactobacillus reuteri / Lactobacillus reuteri?

One of the most studied probiotics in the world

Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) is a probiotic bacterium that has co-evolved with humans since the beginning of time, and because of that it is adapted to its host. L. reuteri is one of the first bacterial species to naturally become established in the microbiota of the new-born. BioGaia’s probiotic products with L. reuteri are among the most scientifically well-documented probiotics in the world in terms of both efficacy and safety.

To date the efficacy and safety of BioGaia’s different strains of L. reuteri have been documented in 258 clinical studies on approximately 21,000 people of all ages (Dec 2022).

127 studies of BioGaia’s strain of L reuteri have been conducted in children, ranging from newborns to 18 years old, and 131 studies in adults.

Positive results have been shown for several gastrointestinal disorders, oral health, and bone health.

The first strain of L. reuteri for human use, L. reuteri DSM 17938, was isolated in 1990 from the breast milk of a Peruvian mother living in the Andes. L. reuteri ATCC PTA 5289 was isolated from the oral cavity of a Japanese woman with exceptional good oral health. L. reuteri ATCC PTA 6475 is an anti-inflammatory strain isolated from breast milk of a Finnish woman.

Today, L. reuteri bacteria are produced under controlled conditions in modern production facilities. For bacteria to grow and duplicate, the right food and temperature are provided. Tests and quality control ensure that each dose contains the right number of viable organisms.

Ingredients

Bulking agent (isomalt), L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475, fully hydrogenated vegetable oil (palm), flavour enhancer (ascorbic acid), mandarin flavoring and mint flavoring. One tablet consists of a minimum of 200 million live L. reuteri Gastrus. Net weight per tablet, 700 mg.

Excessive consumption may have a laxative effect due to the content of sweetener in the product.

Storage: Store in a dry place, not above room temperature (max 25 °C / 77 °F). Keep out of reach of children.

Pregnancy and breast-feeding: The product can be used during pregnancy and breast-feeding.

Dosage

1 chewable tablet per day. Recommended daily dose should not be exceeded. This product should not be used as a substitute for a varied diet.

FAQ

Are there any side effects from taking BioGaia Gastrus probiotics?

Since every gastrointestinal tract is unique some individuals might experience a temporary change in gut motility. BioGaia probiotics very rarely cause side effects in the amounts recommended for the products. Some individuals might experience gas (flatulence), but that generally disappears after a few days. No serious adverse effects have been observed in clinical trials up to the maximum tested dosage of 10 billion CFU per day.

What are probiotics?

Probiotics are good bacteria that can be found in dietary supplements and sometimes in dairy products. Probiotics are defined as ”live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.” (WHO/FAO 2002, Hill C et al. 2014). An important criterium for qualifying as a true probiotic is that health benefits have been proven in clinical studies. Furthermore, a probiotic product must contain the same bacterial strain(s) and the same dose that was used in the clinical studies.

Are multi-strain products better than single-strain probiotic products?

Multi-strain products containing several strains in high doses do not necessarily have a better effect than a single-strain product. Important criteria when choosing a probiotic product are:

• The probiotic bacteria must be defined on strain level

• The probiotic product must have been tested in human clinical studies, with the same dose and with the same bacterial strain(s) as in the commercial product.

Are BioGaia products free from common allergens?

Common allergens such as egg, peanuts, tree nuts, fish, shellfish and soy have not been used in the manufacturing of BioGaia products.

 

If taking medication, pregnant, or breastfeeding please consult a licensed healthcare provider before taking this supplement. Vitamin supplements should not replace a balanced diet. Always read the label. Use as directed. If symptoms persist, talk to your health professional.

*These statements have not been evaluated by the Food & Drug Administration or TGA. These products are not intended to diagnose, treat, cure or prevent any disease. The information contained herein is for informational purposes only and does not establish a doctor-patient relationship.

biogaia gastrus australia lactobacillus reuteri